Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises (AMBALALSA) share price was ₹35.53 at the 28 Oct 2026 close; market capitalisation ₹272 Cr; P/E (TTM) 65.80; sector Healthcare. The share price rose 10.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 67.1% year on year to ₹0.54 Cr and net profit fell 99.6% year on year to ₹0.03 Cr (compared with Jun 2025). Promoters held 31.36% of Ambalal Sarabhai Enterprises in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 43/100 (Weak) as of 28 Oct 2026.
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 29 Oct 2026, 10:39 IST · EPS basis: Consolidated · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,765.80 | 35.03 | 4,23,675 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,653.00 | 87.61 | 2,56,257 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,606.60 | 72.32 | 1,75,220 Cr | 9.54 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,186.60 | 108.03 | 1,18,145 Cr | 22.29 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.30 | 26.29 | 1,17,835 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,338.80 | 34.67 | 1,11,747 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,364.70 | 32.70 | 1,10,248 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Ambalal Sarabhai Enterprises (this company) | ₹35.15 | 65.09 | 269 Cr | 1.70 | 0.00% | 11.24% | 12.37% | 215 Cr | 4 Cr |
| Median 8 companies | ₹1,565.25 | 50.06 | 1,17,990 Cr | 4.71 | 0.47% | 12.98% | 16.41% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Weaknesses
6- Stock is trading at 4.46 times its book value
- Promoter holding is low: 31.4%
- Tax rate seems low
- Company has a low return on equity of 12.1% over last 3 years.
- Earnings include an other income of Rs.9.11 Cr.
- Working capital days have increased from 267 days to 1,379 days
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin -226% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.7 | 0.8 | 0.33 | 0.99 | 1.14 | 0 | 1.17 | 1.73 | 1.64 | 0.79 | 0 | 1.52 | 0.54 |
| Expenses | 4.84 | 2.13 | 1.96 | 1.64 | 2.41 | 1.8 | 3.74 | 3.43 | 2.83 | 2.43 | 0.94 | 2.88 | 1.76 |
| Operating Profit | -3.14 | -1.33 | -1.63 | -0.65 | -1.27 | -1.8 | -2.57 | -1.7 | -1.19 | -1.64 | -0.94 | -1.36 | -1.22 |
| OPM % | -184.71% | -166.25% | -493.94% | -65.66% | -111.4% | — | -219.66% | -98.27% | -72.56% | -207.59% | — | -89.47% | -225.93% |
| Other Income | 1.18 | 1.96 | 1.33 | 3.41 | 1.88 | 6.37 | 10.81 | -3.21 | 8.17 | 1.36 | 2.89 | 3.16 | 1.7 |
| Interest | 0.03 | 0.04 | 0.06 | 0.07 | 0.09 | 0.09 | 0.1 | 0.05 | 0.07 | 0.08 | 0.09 | 0.17 | 0.17 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| PBT | -2.02 | 0.56 | -0.39 | 2.66 | 0.49 | 4.45 | 8.12 | -4.98 | 6.89 | -0.38 | 1.84 | 1.61 | 0.29 |
| Tax % | 0% | 0% | 69.23% | -76.32% | 6.12% | 3.15% | -3.82% | -0.4% | 0% | 0% | -0.54% | -64.6% | 89.66% |
| Net Profit | -2.02 | 0.56 | -0.65 | 4.7 | 0.46 | 4.31 | 8.43 | -4.96 | 6.88 | -0.38 | 1.84 | 2.65 | 0.03 |
| EPS (₹) | -0.26 | 0.07 | -0.08 | 0.61 | 0.06 | 0.56 | 1.1 | -0.65 | 0.9 | -0.05 | 0.24 | 0.35 | 0 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.25 | 6.98 | 1.51 | 0.92 | 0 | 0 | 0 | 0.13 | 3.71 | 3.81 | 4.04 | 3.94 | 2.85 |
| Expenses | 27.3 | 28.62 | 14.47 | 21.76 | 8.86 | 7.86 | 11.69 | 5.71 | 8.87 | 8.61 | 11.37 | 9.06 | 8.01 |
| Operating Profit | -12.05 | -21.64 | -12.96 | -20.84 | -8.86 | -7.86 | -11.69 | -5.58 | -5.16 | -4.8 | -7.33 | -5.12 | -5.16 |
| OPM % | -79.02% | -310.03% | -858.28% | -2265.22% | — | — | — | -4292.31% | -139.08% | -125.98% | -181.44% | -129.95% | -181.05% |
| Other Income | 14.17 | 95.94 | -0.63 | 24.49 | 6.46 | 24.61 | 3.16 | 9.47 | 9.75 | 7.89 | 15.85 | 15.57 | 9.11 |
| Interest | 7.91 | 1.99 | 2.62 | 1.05 | 0.62 | 0.46 | 0.56 | 0.25 | 0.11 | 2.16 | 0.34 | 0.41 | 0.51 |
| Depreciation | 3.36 | 14.62 | 2.45 | 0.42 | 0.4 | 0.39 | 0.38 | 0.19 | 0.15 | 0.12 | 0.1 | 0.09 | 0.08 |
| PBT | -9.15 | 57.69 | -18.66 | 2.18 | -3.42 | 15.9 | -9.47 | 3.45 | 4.33 | 0.81 | 8.08 | 9.95 | 3.36 |
| Tax % | 0% | 20.8% | 10.18% | 166.06% | 13.45% | 2.2% | -0.84% | 14.49% | 5.31% | -217.28% | -1.98% | -10.45% | — |
| Net Profit | -9.15 | 45.68 | -20.57 | -1.44 | -3.88 | 15.55 | -9.39 | 2.96 | 4.11 | 2.58 | 8.24 | 10.99 | 4.14 |
| EPS (₹) | -1.19 | 5.96 | -2.68 | -0.19 | -0.51 | 2.03 | -1.23 | 0.39 | 0.54 | 0.34 | 1.08 | 1.43 | 0.54 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 | 76.63 |
| Reserves | -73.49 | -27.8 | -46.41 | -47.98 | -51.85 | -36.39 | -45.85 | -42.93 | -38.79 | -36.34 | -28.14 | -17.15 |
| Borrowings | 30.1 | 29.54 | 22.13 | 11.07 | 11.07 | 11 | 11.14 | 9.77 | 11.49 | 10.03 | 7.66 | 11 |
| Other Liabilities | 103 | 65.13 | 63.81 | 91.28 | 103 | 73.35 | 58.14 | 39.53 | 30.42 | 30.96 | 26.77 | 15.31 |
| Total Liabilities | 136 | 144 | 116 | 131 | 139 | 125 | 100 | 83 | 79.75 | 81.28 | 82.92 | 85.79 |
| Fixed Assets | 42.66 | 20.6 | 16.43 | 14.98 | 14.65 | 14.48 | 13.97 | 13 | 12.86 | 12.84 | 12.22 | 12.13 |
| CWIP | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 56.29 | 82.91 | 76.19 | 55.88 | 55.97 | 56.43 | 26.58 | 25.54 | 25.54 | 25.39 | 25.34 | 25.34 |
| Other Assets | 37.43 | 39.99 | 23.54 | 60.14 | 68.01 | 53.68 | 59.51 | 44.46 | 41.35 | 43.05 | 45.36 | 48.32 |
| Total Assets | 136 | 144 | 116 | 131 | 139 | 125 | 100 | 83 | 79.75 | 81.28 | 82.92 | 85.79 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -12.05 | -69.37 | -3.67 | -12.66 | -3.27 | -4.53 | -10.42 | -7.79 | 1.52 | -3.82 | -4.08 | -0.26 |
| Investing | 12.7 | 75.22 | 8.64 | 26.14 | 2.37 | 4.92 | 15.76 | 20.77 | 0.61 | 3.48 | 6.35 | -3.02 |
| Financing | -0.75 | -2.56 | -8.14 | -12.15 | -0.44 | -0.42 | -0.32 | -16.46 | -3.76 | 0.3 | -2.31 | 3.4 |
| Net Cash Flow | -0.1 | 3.3 | -3.17 | 1.33 | -1.33 | -0.03 | 5.02 | -3.47 | -1.63 | -0.04 | -0.04 | 0.11 |
| Free Cash Flow | -0.49 | 31.11 | -3.04 | 1.72 | -3.33 | -4.5 | 0.66 | 11.47 | 1.58 | -3.91 | 1.11 | -0.27 |
| CFO/EBITDA | 71 | 304 | 27 | -24 | -11 | 51 | 85 | 128 | -45 | 65 | 47 | 61 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.34 | 1.57 | 0 | 0 | — | — | — | 421 | 29.51 | 37.36 | 37.04 | 38.91 |
| Inventory Days | 76.36 | 22.52 | 47.93 | 56.64 | — | — | — | 0 | 2.01 | 0 | 0 | 6.62 |
| Days Payable | 321 | 729 | 3,974 | 13,253 | — | — | — | — | 1,612 | — | — | 712 |
| Cash Conversion Cycle | -207 | -705 | -3,927 | -13,197 | — | — | — | 421 | -1,580 | 37.36 | 37.04 | -667 |
| Working Capital Days | -2,355 | -3,036 | -16,106 | -23,785 | — | — | — | -30,660 | -1,038 | -687 | 109 | 1,379 |
| ROCE % | -34.09% | -59.62% | -12.82% | -21.98% | -7.41% | 36.9% | -4.27% | 9.93% | 11.12% | 5.96% | 6.01% | 16.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ambalal Sarabhai Enterprises insights
40 extracted metrics + investor summaries across FY15–FY27.
Documents
Frequently Asked Questions about Ambalal Sarabhai Enterprises
What does Ambalal Sarabhai Enterprises Ltd do?
Where is Ambalal Sarabhai Enterprises Ltd (AMBALALSA) listed?
Which sector does Ambalal Sarabhai Enterprises Ltd belong to?
What is the market capitalisation of Ambalal Sarabhai Enterprises Ltd?
What is the PE ratio of Ambalal Sarabhai Enterprises Ltd?
What is the 52-week high and low of Ambalal Sarabhai Enterprises Ltd?
What is the Return on Equity (ROE) of Ambalal Sarabhai Enterprises Ltd?
Company Information
Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/500009.md for Ambalal Sarabhai Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.